Product
ETX101
3 clinical trials
1 indication
Indication
Dravet syndromeClinical trial
WAYFINDER: A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet SyndromeStatus: Recruiting, Estimated PCD: 2029-12-01
Clinical trial
ENDEAVOR: A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Infants and Children With SCN1A-Positive Dravet SyndromeStatus: Recruiting, Estimated PCD: 2027-04-01
Clinical trial
EXPEDITION: A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet SyndromeStatus: Recruiting, Estimated PCD: 2029-12-01